43 assets in Liver Disorder

Therapeutic assets addressing Liver Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Metformin Liver Disorder	Taipei City Hospital	P4	BBB (72)
Empagliflozin Liver Disorder	Military University Hospital, Prague	P4	BB (71)
10-(1-methylpiperidin-4-ylidene)-5,10-dihydro-4H-benzo[5,6]cyclohepta[1,2-b]thiophen-4-one Liver Disorder	Tanta University	P4	BB (69)
Alpha Tocopherol Liver Disorder	Tanta University	P4	BB (66)
Heplisav-B Liver Disorder	Mercy Medical Center	P4	BB (65)
Efinopegdutide Liver Disorder	Merck Sharp & Dohme LLC	P2	BB (64)
Lactulose Liver Disorder	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	P4	BB (64)
Rifaximin Liver Disorder	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	P4	B (62)
Human Placenta Hydrolysate Liver Disorder	Green Cross Wellbeing	P3	B (60)
Zinc Acexamate Liver Disorder	Hospital Universitari Vall d'Hebron Research Institute	P3	B (60)
Viosterol Liver Disorder	Chulalongkorn University	P4	B (59)
Sirolimus Liver Disorder	Nottingham University Hospitals NHS Trust	P2	B (57)
azd2389 Liver Disorder	AstraZeneca	P1	CCC (52)
Selvigaltin Liver Disorder	Galecto Biotech AB	P1/2	CCC (48)
Admilparant Liver Disorder	Bristol-Myers Squibb	P1	CC (47)
Asundexian Liver Disorder	Bayer	P1	CC (47)
azd2693 Liver Disorder	AstraZeneca	P1	CC (47)
Bms-986369 Liver Disorder	Celgene	P1	CC (47)
Bocidelpar Liver Disorder	Astellas Pharma Global Development, Inc.	P1	CC (47)
Caffeine Liver Disorder	AstraZeneca	P1	CC (47)
Camizestrant Liver Disorder	AstraZeneca	P1	CC (47)
Elacestrant Liver Disorder	Stemline Therapeutics, Inc.	P1	CC (47)
fia586 Liver Disorder	Novartis Pharmaceuticals	P1	CC (47)
Midazolam Liver Disorder	AstraZeneca	P1	CC (47)
(+)-Quinidine Liver Disorder	AstraZeneca	P1	CC (47)
Repotrectinib Liver Disorder	Bristol-Myers Squibb	P1	CC (47)
rtx001 Liver Disorder	Resolution Therapeutics Limited	P1/2	CC (47)
Saroglitazar Liver Disorder	Zydus Therapeutics Inc.	P1	CC (47)
Seladelpar Liver Disorder	Gilead Sciences	P1	CC (47)
Tvb-2640 - Liver Disorder	Sagimet Biosciences Inc.	P1	CC (47)
Survodutide Liver Disorder	Boehringer Ingelheim	P1	CC (46)
azd6234 Liver Disorder	AstraZeneca	P1	CC (43)
azd9550 Liver Disorder	AstraZeneca	P1	CC (43)
Elebsiran Liver Disorder	Vir Biotechnology, Inc.	P1	CC (43)
Incb123667 Liver Disorder	Incyte Corporation	P1	CC (43)
Tobevibart Liver Disorder	Vir Biotechnology, Inc.	P1	CC (43)
Siremadlin Liver Disorder	Novartis Pharmaceuticals	P1	CC (42)
Ganwei Liver Disorder	Taipei City Hospital	N/A	D (30)
Huazhi Rougan Granule Liver Disorder	Nanjing First Hospital, Nanjing Medical University	N/A	D (30)
Lenvatinib Liver Disorder	Sun Yat-sen University	N/A	D (30)
Vitamin D Liver Disorder	Taoyuan General Hospital	N/A	D (30)
Avenciguat Liver Disorder	Boehringer Ingelheim	P2	D (29)
Mdr-001 Liver Disorder	MindRank AI Ltd	P1	NR ()